GLP-1 Drugs Like Ozempic: Surprising Health Benefits and Potential Drawbacks

Surprising Health Benefits of GLP-1 Drugs

• 💡 A study of 92,000 people suggests semaglutides (found in drugs like Ozempic and Wegovy) are linked to a 33% lower risk of dementia.
• 🧠 Evidence also indicates these drugs may help reduce sleep apnea and seizures, and can slow the progression of chronic kidney disease.
• 🚀 Clinical trials are exploring their use for curbing alcohol and tobacco cravings.

Understanding the Mechanisms and Side Effects

• 🎯 A significant portion of the observed benefits, particularly for conditions like dementia, kidney disease, and stroke, may be attributed to weight loss.
• ⚠️ While common gastrointestinal issues are known, more serious side effects like pancreatitis, potential links to thyroid tumors, and gallstone attacks occur more frequently than often advertised.
• 📉 Many of the benefits, especially weight reduction, can disappear when the injections are stopped.

Access and Affordability of GLP-1 Medications

• 💰 The high cost of these drugs is a major limitation, but coverage under Medicare and Medicaid is being considered, potentially by 2026.
• ✅ This expanded access would greatly benefit high-risk populations by providing cardiovascular and kidney disease protection.
• ⚠️ Clinicians must still perform careful patient selection and risk-to-benefit ratio assessments for each individual.

Counterfeit and Compounded Drugs

• 🚫 Due to past shortages, compounded versions of these drugs became prevalent, often prescribed via telemedicine.
• 🔬 The FDA now advises against using compounded drugs as the shortage is officially over.